Gal­der­ma tar­gets one of this year's biggest Eu­ro­pean IPOs with top-of-the-range share price

Gal­der­ma, a skin­care com­pa­ny that al­so has an R&D pipeline, is set to start trad­ing on the SIX Swiss Ex­change Fri­day at a pre­mi­um price of CHF 53 ($59.31) per share, plac­ing its IPO val­ue at CHF 2.3 bil­lion ($2.6 bil­lion).

The Zug-based en­ti­ty is main­ly known for con­sumer brands such as Cetaphil and Dif­ferin. Last week, Gal­der­ma said it planned to price its pub­lic de­but be­tween CHF 49 to CHF 53 apiece. The shares will be list­ed as “GALD” on Fri­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.